Barbara A Burtness M.D.
Oncologist | Medical Oncology
333 Cottman Ave Philadelphia PA, 19111About
Dr. Barbara Burtness is an oncologist practicing in Philadelphia, PA. Dr. Burtness specializes in the care and treatment of patients with cancer. As an oncologist, Dr. Burtness manages and oversees the treatment of a cancer patient after he or she has been diagnosed with the disease. Oncologists will care for their patients throughout the course of the disease. Types of oncologists include medical oncologists, surgical oncologists, radiation oncologists, gynecologic oncologists, pediatric oncologists and hematologist oncologists.
Education and Training
Stony Brook Univ Health Sciences Center School Of Medicine 1986
Provider Details
Expert Publications
Data provided by the National Library of Medicine- A phase I study of paclitaxel for mobilization of peripheral blood progenitor cells.
- Total-body echo-planar MR imaging in the staging of breast cancer: comparison with conventional methods--early experience.
- Preoperative chemoradiation for esophageal cancer.
- Dose escalation and pharmacokinetic study of irinotecan in combination with paclitaxel in patients with advanced cancer.
- The feasibility of high-dose chemotherapy in breast cancer patients with impaired left ventricular function.
- Use of paclitaxel in patients with pre-existing cardiomyopathy: a review of our experience.
- Improved method for the detection of cytokeratin 19-positive cells in the peripheral blood of breast cancer patients.
- Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
- Five-year update of an expanded phase II study of dose-dense and -intense doxorubicin, paclitaxel and cyclophosphamide (ATC) in high-risk breast cancer.
- Vascular endothelial growth factor, FLT-1, and FLK-1 analysis in a pancreatic cancer tissue microarray.
- Postchemotherapy MRI overestimates residual disease compared with histopathology in responders to neoadjuvant therapy for locally advanced breast cancer.
- Novel targets in pancreatic cancer: focus on future paths to therapy.
- Long-term assessment of cardiac function after dose-dense and -intense sequential doxorubicin (A), paclitaxel (T), and cyclophosphamide (C) as adjuvant therapy for high risk breast cancer.
- Epidermal growth factor receptor inhibition in head and neck cancer--more insights, but more questions.
- A randomized phase II study of ixabepilone (BMS-247550) given daily x 5 days every 3 weeks or weekly in patients with metastatic or recurrent squamous cell cancer of the head and neck: an Eastern Cooperative Oncology Group study.
Barbara A Burtness M.D.'s Practice location
Philadelphia, PA 19111Get Direction
Barbara A Burtness M.D.'s reviews
Write ReviewPatient Experience with Dr. Burtness
Recommended Articles
- Night Sweats and Lymphoma
LymphomaLymphoma is a type of cancer that begins in the lymphatic system, particularly in the disease-fighting immune cells called lymphocytes. These cells are found in the bone marrow, lymph nodes, thymus, spleen, and other parts of the body. In lymphoma, lymphocytes are altered and tend to...
- What Is the Life Expectancy for Bladder Cancer?
What is a bladder?The bladder can be described as a hollow organ, which is located next to the kidneys. The bladder functions by collecting all the urine coming from the kidneys through the ureter. It then stores the urine until it is removed from the body.Having a bladder cancer causes an...
- Squelching Ovarian Cancer: The Not-So-Silent Killer
Regardless of its widely-known nickname, ovarian cancer is not really a silent killer. There are symptoms, but they are fairly noticeable or commonly mistaken for another condition, such as irritable bowel syndrome. As a result, the search progresses for new biomarkers, more positive outcomes, as...
- Risk-Reduction Mastectomy for those with Ovarian Cancer
A risk-reducing mastectomy is a type of surgical procedure that involves the removal of a woman’s breasts when there is an increased risk of developing breast cancer, yet there is no sign of breast cancer. Any woman who has had breast cancer is considered at high-risk of developing breast cancer...
- Limit Your Risk for Prostate Cancer with Statins
A recent study has shown that the levels of prostate specific antigen (PSA), a marker of prostate cancer, lower in men who take statin drugs. This may lower the risk of advanced prostate cancer in men, according to a study published in the Journal of the National Cancer Institute.High levels of PSA...
- What Is Colorectal Cancer?
Cancer of the tissue in the colon or rectum is referred to as colorectal cancer. Cancer arises due to the abnormal growth and division of tissues in one of these organs. The uncontrolled division and growth of the cells in the colon or rectum result in the formation of a tumor. This cancer has a...
Nearby Providers
- Dr. Vijay K. Gandhi M.D.333 COTTMAN AVE PHILADELPHIA PA 19111
- Dr. Jon Glass MD909 Walnut St Philadelphia PA 19107
- Dr. Crystal S. Denlinger M.D.333 COTTMAN AVE PHILADELPHIA PA 19111
- Eiko Klimant201 West Evergreen Avenue Philadelphia Pennsylvania 19118
- Dr. Shayma Master Kazmi MD1331 E Wyoming Ave Philadelphia PA 19124
- Dr. Sunita Dwivedy Nasta MD3400 Spruce St Philadelphia PA 19104